CD19-targeting monoclonal antibody

This page covers all CD19-targeting monoclonal antibody drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting CD19.

Targets

CD19

Phase 3 pipeline (1)

• A arm (DA-90) · Polish Adult Leukemia Group · Oncology
  DA-90 is a monoclonal antibody targeting CD19.

Phase 2 pipeline (2)

• BTV100 High dose · BioTheraVision, Inc. · Oncology
  BTV100 is a monoclonal antibody targeting CD19.
• BTV100 Mid dose · BioTheraVision, Inc. · Oncology
  BTV100 is a monoclonal antibody targeting CD19.

Patent intelligence

• cd19 targeting monoclonal antibody patent landscape — aggregated cliff calendar, attackable patents, originator estates